Skip to main content

Transforming growth factor alpha, amphiregulin and cripto- 1 are frequently expressed in advanced ovarian carcinomas

d'Antonio, Antonio, Losito, Simona, Pignata, Sandro, Grassi, Michele, Perrone, Francesco, de Luca, Antonella, Tambaro, Rosa, Bianco, Caterina, Gullick, William J., Johnson, Gibbes R., and others. (2002) Transforming growth factor alpha, amphiregulin and cripto- 1 are frequently expressed in advanced ovarian carcinomas. International Journal of Oncology, 21 (5). pp. 941-948. ISSN 1019-6439. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:22655)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.

Abstract

The expression of transforming growth factor alpha (TGFalpha), amphiregulin (AR) and cripto-1 (CR-1) was assessed by immunohistochemistry in 83 specimens (59 primary ovarian tumors and 24 extra-ovarian carcinomas) that were obtained from 68 ovarian carcinoma patients. Within the 59 primary tumors, 54 (92%) expressed immunoreactive TGFalpha, 45 (76%) expressed AR, and 28 (47%) expressed CR-1. The expression of AR and CR-1 mRNAs in the ovarian carcinomas was also demonstrated by RT-PCR analysis. Seventeen extra-ovarian specimens (71%) were found to express CR-1, whereas AR and TGFalpha were expressed respectively in 21 (87%) and 22 (92%) extra-ovarian tissues. In 15 cases for whom both ovarian and extra-ovarian tissues were available, a statistically significant higher expression of CR-1 was found in extra-ovarian specimens. A statistically significant correlation was found between AR expression in the ovarian carcinomas and both low grade and low proliferative activity. Finally, expression of TGFalpha was predictive of longer progression-free survival. These data strongly suggest that the EGF-related peptides might be involved in the pathogenesis and outcome of human ovarian cancer.

Item Type: Article
Uncontrolled keywords: cripto-1; amphiregulin; TGF alpha; ovarian cancer; prognosis
Subjects: Q Science
R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions: Divisions > Division of Natural Sciences > Biosciences
Depositing User: William Gullick
Date Deposited: 25 Sep 2009 13:18 UTC
Last Modified: 16 Nov 2021 10:01 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/22655 (The current URI for this page, for reference purposes)

University of Kent Author Information

Gullick, William J..

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.